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NAD(P)H oxidase has been shown to be important
in the development of salt-sensitive hypertension.
Here, we show that the expression of a subunit of
NAD(P)H oxidase, p67phox, was increased in
response to a high-salt diet in the outer renal medulla
of the Dahl salt-sensitive (SS) rat, an animal model for
human salt-sensitive hypertension. The higher
expression of p67phox, not the other subunits
observed, was associated with higher NAD(P)H
oxidase activity and salt sensitivity in SS rats
compared with a salt-resistant strain. Genetic muta-
tions of the SS allele of p67phox were found in the
promoter region and contributed to higher promoter
activity than that of the salt-resistant strain. To verify
the importance of p67phox, we disrupted p67phox in
SS rats using zinc-finger nucleases. These rats
exhibited a significant reduction of salt-sensitive
hypertension and renal medullary oxidative stress
and injury. p67phox could represent a target for salt-
sensitive hypertension therapy.
INTRODUCTION
Essential hypertension is a multifactorial disease affecting nearly
27% of the world population (Kearney et al., 2005) and is a major
risk factor for stroke, heart failure, and end-stage renal disease.
Excess dietary salt intake is an important environmental factor in
the etiology of hypertension, and the susceptibility of individuals
to salt intake (salt sensitivity) is, in part, genetically determined.
Therefore, it is of great interest to identify genes contributing to
salt sensitivity.
The Dahl salt-sensitive (SS) rat, which shares many pheno-
typic traits seen in African American hypertensive patients (Cow-
ley and Roman, 1996; Cowley et al., 2001; Jones et al., 2002;
Rostand et al., 1982), has been used extensively to dissect the
genetic complexity and related mechanisms contributing to
salt-sensitive hypertension. Our interest in p67phox, one of the
cytosolic subunits of NAD(P)H oxidase, resulted from character-
izing a panel of congenic strains derived from the SS rat and theCell Msalt-resistant Brown Norway (BN) rat (Moreno et al., 2007). One
of the congenic strains, SS.13BN26, containing a 16.0 megabase
(Mb) genomic region from the BN rat substituted into Chromo-
some 13 of SS rats, was found to have a significant reduction
of salt-sensitive hypertension and renal injury compared with
the SS rat (Lu et al., 2010). p67phox was found to be located in
the BN introgressed region of this congenic strain.
For many decades, the only pathological condition in which
NAD(P)H oxidase was recognized to be of importance was
chronic granulomatous disease (Kuhns et al., 2010). It is now
recognized that this enzyme also plays an important role in the
development and progression of cardiovascular disease
(Brandes et al., 2010), including hypertension (Landmesser
et al., 2002; Laursen et al., 1997; Rajagopalan et al., 1996).
NAD(P)H oxidase is a multisubunit enzyme comprised of the
membrane subunits gp91phox and p22phox and the cytosolic
subunits p47phox, p67phox, p40phox, and Rac 1 or 2 (Paravicini
and Touyz, 2008). All of the cytosolic subunits assemble on the
membrane upon activation, allowing the enzyme to generate
superoxide (O2
.). Most functional studies concerning the role
of this enzyme in hypertension have focused on the central
nervous system (Infanger et al., 2006) and peripheral vascula-
ture. However, there is evidence that NAD(P)H oxidase contrib-
utes to oxidative stress that occurs in the renal outer medulla
(OM) with increased salt intake in SS rats (Taylor et al., 2006).
Direct interstitial infusion of an NAD(P)H oxidase inhibitor
apocynin into the OM of SS rats attenuated salt-sensitive hyper-
tension by nearly 50%. Since p67phox is the only known NAD(P)H
oxidase subunit located in the introgressed region of congenic
SS.13BN26, we determined whether genetic variances in
p67phox of the SS rat could increase expression of the gene
and thereby upregulate the activity of the enzyme, contributing
to increased salt sensitivity in SS rats. We then generated
a p67phox-null mutant (p67phox/) rat and demonstrated that
disruption of p67phox in SS rats reduced salt-sensitive hyperten-
sion and renal oxidative stress and injury.
RESULTS
Genetic Variances in the Promoter Region of p67phox
Affect Promoter Activity and Gene Expression
We performed real-time quantitative RT-PCR (qRT-PCR) to
analyze messenger RNA (mRNA) expression of p67phox. Ratsetabolism 15, 201–208, February 8, 2012 ª2012 Elsevier Inc. 201
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Figure 1. Genetic Variances in the Promoter Region of p67phoxAffect
Promoter Activity and Gene Expression
(A) Quantitative real-time PCR of p67phox of rats (n = 6 rats/strain/time point) on
both 0.4% low salt (LS), and day 7 of 8% high salt (D7-HS).
(B) Schematic of constructed SS and SS.13BN26 p67phox promoters. The SS
p67phox promoter not only contains 204 bp deletions, but also has 4 SNPs
downstream of the deletion.
(C) Luciferase activity of both SS and SS.13BN26 p67phox promoters (n = 8–9/
construct).
Data are presented as mean values ± SE. *p < 0.05 significant difference from
SS. See also Figure S1.
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p67phox in Salt-Sensitive Hypertensionwere fed on a 0.4% NaCl diet (low salt, LS) since weaning. At
6 weeks of age, a subgroup of these rats was switched to an
8% NaCl diet (high salt, HS). Outer medullary tissue was
collected from rats on the LS diet and from rats on the HS diet
7 days after their diets were switched. The average mRNA levels
of p67phox were increased in both the SS rat and congenic
SS.13BN26 after the diet was switched from LS to HS. The
mRNA levels of p67phox were significantly higher in SS rats
than in SS.13BN26 rats on both the LS diet and day 7 of the HS
diet (Figure 1A).
Since the p67phox sequence had not been determined in rats,
we sequenced the coding region and 1700 base pairs (bp)
upstream of the translation start site of SS and SS.13BN26 rats.
Within the 15 exons of p67phox, only a single silent mutation
was found in exon 14. The coding sequences of the SS and con-
genic SS.13BN26 alleles of p67phox were reported with the Gen-
Bank accession numbers JN864041 and JN864042, respec-
tively. The analysis of the promoter sequence revealed that SS
rats had a 204 bp deletion and four single-nucleotide polymor-
phisms (SNPs) compared to SS.13BN26 rats (Figure S1 available
online). To determine whether these variants would yield differ-
ences in the promoter activity, two constructs of the promoter
containing all the genetic variances (Figure 1B) were cloned
into luciferase constructs. The promoters were transfected into
immortalized rat medullary thick ascending limb cells (raTAL).
The promoter activity of p67phox as assessed by luciferase fluo-
rescence was 1.7-fold higher in the SS construct than in the
SS.13BN26 construct (p = 0.009; Figure 1C). These results indi-
cate that the genetic variances in the promoter region may
contribute to higher mRNA expression of p67phox in the SS
compared to SS.13BN26 rats on both LS and HS diet.202 Cell Metabolism 15, 201–208, February 8, 2012 ª2012 Elsevier InEnhanced p67phox Expression in Renal Outer Medulla Is
Associatedwith IncreasedNAD(P)HOxidaseActivity and
Enhanced Salt Sensitivity in SS Rats
In separate groups of SS and congenic SS.13BN26 rats, outer
medullary tissue was collected from 6-week-old rats on the LS
diet and day 7 of the HS diet to determine protein expression
of p67phox and NAD(P)H oxidase activity. p67phox was undetect-
able by western blot in both strains of rats fed the LS diet (Fig-
ure 2A) but was significantly higher in the SS rats compared to
SS.13BN26 rats on day 7 of the HS diet (p = 0.008). Notably,
none of the other membrane or cytosolic subunits of NAD(P)H
oxidase, including p22phox, gp91phox, p47phox, and Rac 1,
differed between the two strains on day 7 of the HS diet
(Figure S2).
Renal medullary NAD(P)H oxidase activity was determined
with a dihydroethidium (DHE) fluorescence assay (Taylor et al.,
2006). NAD(P)H oxidase activity increased significantly in
response to the HS diet in SS rats (p < 0.01). Differences in
enzyme activity between the two strains were not observed
in rats fed the LS diet, whereas significantly higher levels of
activity were found on day 7 of the HS diet in SS compared
with SS.13BN26 rats (p < 0.01) (Figure 2B).
Mean arterial pressure (MAP) was determined by telemetry.
Congenic SS.13BN26 rats were shown to be protected against
salt-sensitive hypertension compared with SS rats (Figure 2C).
MAP between SS and congenic SS.13BN26 rats was statisti-
cally different on days 7, 10, and 14 of the HS diet (p <
0.001). After 14 days, the MAP of SS.13BN26 rats was nearly
30 mmHg lower than that of the SS rats. Together, these
results indicate that it is the greater expression of p67phox—
not p22phox, gp91phox, p47phox, or Rac 1—that is associated
with greater levels of renal medullary NAD(P)H oxidase activity
on the HS diet and greater salt sensitivity in SS rats compared
to SS. 13BN26.
p67phox-Null Mutant SS Rat Is Generated
with Zinc-Finger Nuclease Technology
To determine the functional relevance of p67phox in the develop-
ment of salt-sensitive hypertension in SS rats, we generated
a p67phox/ model in the genomic background of SS rats using
zinc-finger nucleases (ZFNs) (Geurts et al., 2009; Geurts et al.,
2010) (for details, see the Experimental Procedures). Genomic
DNA of p67phox-null mutant (p67phox/) rats was sequenced.
Sequencing results suggested there was a 5 bp deletion
(GAGAA) in the genomic sequence of p67phox/ rats (Figure 3A).
The p67phox/ rats were also validated by western blot experi-
ments (Figure S3). In order to further demonstrate that there
was no functional p67phox in p67phox/ rats, respiratory burst
experiments were performed. p67phox is known to be critically
involved in the respiratory burst of macrophages (Maehara
et al., 2009; Noack et al., 1999). We obtained macrophages
from the peritoneal space of 6- to 7-week-old p67phox/ rats
and wild-type (WT) littermates fed the HS diet for 14 days (De
Miguel et al., 2010). The respiratory burst response to phorbol
12-myristate 13-acetate (PMA) stimulus in the p67phox/ rats
was completely abolished compared to the WT littermates (Fig-
ure 3B). We concluded that we had successfully generated the
p67phox/ rats. p67phox/ rats and their WT littermates were
used for the following phenotypic studies.c.
A B
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Figure 2. Greater p67phox Expression Is Associated
with Greater NAD(P)H Oxidase Activity and Salt
Sensitivity in the SS Rat
(A) Western blot densitometric analyses of p67phox (b-actin
normalized) of rats on both 0.4% LS and day 7 of HS diet
with the associated gel shown (n = 5 rats/strain/time point).
*p < 0.05 significant difference from SS.
(B) NAD(P)H oxidase activity of rats on both LS and D7-HS
(n = 11–12 rats/strain/time point). *p < 0.01 significant
difference from LS within strain; yp < 0.01 significant
difference from SS.
(C)Mean arterial pressure (MAP) of 5- to 6-week-old rats on
both 0.4%and8%salt diet (n =8–10 rats/strain). yp<0.001
significant difference between strains at that time point.
Data are presented as mean values ± SE. See also
Figure S2.
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Sensitivity and Renal Oxidative Stress
We first examined the effect of disrupting p67phox on blood pres-
sure. Baseline MAP was not different between the WT and
p67phox/ rats at 6weeks of agewhen fed the LSdiet (Figure 4A).
MAPbetweenWTandp67phox/ ratswasstatisticallydifferenton
days 10 and14 of theHSdiet (p < 0.001). By the endof day 14, the
MAP of p67phox/ rats was 30 mmHg lower than their WT litter-
mates. These results suggest that p67phox had a profound effect
on the development of salt-sensitive hypertension in SS rats.
We then measured NAD(P)H oxidase activity and total super-
oxide levels using outer medullary tissue homogenate. OM was
harvested at the end of blood pressure measurement on day 14
of the HS diet. The p67phox/ rats demonstrated significantly
lower renal medullary NAD(P)H oxidase activity (p = 0.0049) (Fig-
ure 4B).Weused the portion ofO2
. thatwas inhibitedbydipheny-
lene iodonium (DPI) as an index of NAD(P)H oxidase activity as
previously described (Taylor et al., 2006). Since DPI is recognized
as a nonselective inhibitor of all FAD-containing enzymes,
including xanthine oxidase, cytochrome p450 oxidoreductase,
NADH dehydrogenase, and others (Drummond et al., 2011), the
residual O2
. level in the p67phox/ rats was likely derived from
non-specificDPI inhibitionofotherO2
.generatingenzymes.TotalCell Metabolism 15, 20renal medullary O2
. levels was also significantly
lower in the p67phox/ rats (p = 0.01) (Figure 4C).
To further validate that oxidative stress was
reduced in p67phox/ rats, outer medullary
hydrogen peroxide (H2O2) levels weremeasured
in anesthetized rats. In a separate group of
p67phox/ rats and WT littermates, microdialy-
sis techniques were used to collect interstitial
fluid from the outer medullary region, and H2O2
levels were measured with the Amplex Red
assay (Jin et al., 2009). As shown in Figure 4D,
H2O2 concentrations in the medullary interstitial
fluid of p67phox/ rats were significantly lower
than WT littermates (p = 0.019).
p67phox–/– Rats Show Significantly
Reduced Renal Injury
To evaluate the degree of renal injury, protein-
uria and microalbuminuria were measured.Urine was collected overnight (18 hr) on the LS diet and on
days 7 and 14 of the HS diet. In rats fed the LS diet, no differ-
ences were observed between WT and p67phox/ rats. Protein
excretion of WT rats increased from 14.4 ± 1.8 mg/day on the
LS diet to 122.8 ± 18.7 mg/day on day 7 and to 331.2 ±
50.5 mg/day on day 14 of the HS diet. In contrast, p67phox/
rats exhibited only half of these levels in response to the HS
diet (Figure 5A). Microalbumin excretion followed the same trend
(Figure 5B).
Histological analyses of the kidneys collected on day 14 of
the HS diet were also used to quantify the renal injures
between WT and p67phox/ rats. Trichrome staining was
used to quantify protein casts (stained in red), an index of
tubular necrosis. Protein casts were mostly observed in the
OM region at levels that were 7-fold higher in WT compared
with p67phox/ rats (p < 0.001) (Figure 5C). Interstitial fibrosis
was quantified by a-SMA immunostaining (Figure 5D), and in-
filtrated macrophages were quantified by ED-1 immunostain-
ing (Figure 5E). a-SMA and ED-1 were stained in brown. In
the outer medullary area, the levels of interstitial fibrosis and
infiltrated macrophages in p67phox/ rats were half the levels
found in WT rats (p = 0.008 and 0.008, respectively). Glomer-
ular injury was quantified by scoring 50 superficial cortical1–208, February 8, 2012 ª2012 Elsevier Inc. 203
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Figure 3. The p67phox-Null Mutant Rat Model Is Validated
(A) Sequencing of genomic DNA of wild-type (WT) and p67phox/ rats revealed a 5 bp deletion (GAGAA) in the genomic sequence of p67phox/ rats (n = 3 rats/
strain).
(B) Respiratory burst of macrophages isolated from p67phox/ (n = 6) and WT (n = 4) rats in response to phorbol 12-myristate 13-acetate (PMA), a PKC activator,
administered at time zero. Data are presented as mean values ± SE.
See also Figure S3.
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rats and their WT littermates (Mori and Cowley, 2004). As
shown in Figure 5F, the glomerular injury was significantly
reduced in the superficial cortical glomeruli of p67phox/
rats (similar reduction in the juxtamedullary glomeruli; data
not shown). Overall, p67phox/ rats showed dramatic reduc-
tions of renal injury in both the OM and cortex. These results
indicate that p67phox plays a causal role in the development of
salt-sensitive hypertension and renal oxidative stress and
injury.
DISCUSSION
p67phox is known to be a key activator of NOX2-containing
NAD(P)H oxidase in phagocytes (Maehara et al., 2009; Noack
et al., 1999). However, the direct role of p67phox in the develop-
ment of salt-sensitive hypertension and renal injury has not
been explored previously. The results of the present study using
p67phox/ rats provide strong evidence of an important role for
this gene in salt-sensitive hypertension. Even in the face of very
large increases of salt intake, suppression of p67phox produced
significant reductions of hypertension, oxidative stress, and
renal injury.
p67phox was cloned and identified in the renal OM. Several
genetic variances between SS and SS.13BN26 rats were found
in the promoter region and contributed to higher promoter
activity, perhaps explaining the higher p67phox mRNA expres-
sion in the OM of SS rats. It will now be important to identify
the upstream transcription factors that differentially regulate
p67phox expression through the genetic variances. The SS
allele of the p67phox promoter contains a 204 bp deletion
compared to the SS.13BN26 allele, yet the SS allele yielded
higher promoter activity. This result suggests that there might
be some transcriptional repressors binding to the deleted
region. It will now be important to identify potential transcrip-
tional factors that bind to this region and to validate
the binding with chromatin immunoprecipitation (ChIP)
experiments.204 Cell Metabolism 15, 201–208, February 8, 2012 ª2012 Elsevier InIn our current study, we also observed that p67phox expres-
sion—not the expression of p22phox, gp91phox, p47phox or
Rac1—in the outer medullary region is associated with higher
NAD(P)H oxidase activity and greater salt sensitivity in SS
rats. There is immunohistochemical evidence from kidneys of
SHR rats suggesting that p67phox is expressed in the thick
ascending limb, macula densa, distal convoluted tubule,
cortical collecting duct, and perhaps the outer and inner medul-
lary collecting ducts (Chabrashvili et al., 2002). We have
confirmed these findings by immunostaining a single Sprague
Dawley kidney. Additionally, we found no staining in the vasa
recta of the outer medulla. Among different tubules in the outer
medulla, the mTAL has been previously shown to produce
greater amounts of O2
. than the thin descending limb and
outer medullary collecting duct (Li et al., 2002). Moreover,
increased luminal flow rate and/or [Na+] can stimulate the
generation of O2
. in mTAL (Abe et al., 2006). Increased levels
of O2
. can enhance Na+ entry via Na+K+2Cl cotransport and
therefore increase Na+ reabsorption (Juncos and Garvin, 2005).
It remains to be determined whether the mTAL of the SS rats
exhibits higher levels of p67phox expression and NAD(P)H
oxidase activity in response to a HS diet than the mTAL of con-
genic SS.13BN26.
A growing body of evidence suggests that T cells play an
important role in the later phase of the development of hyper-
tension (Harrison et al., 2011). In SS rats after 3 weeks of
a HS diet, significant infiltration of T cells was observed in
the kidney (De Miguel et al., 2011). These T cells were found
to express NAD(P)H oxidase subunits—including p22phox,
gp91phox, p47phox, and p67phox—indicating that T cells
contain the molecular machinery needed for O2
. production.
Administration of an immunosuppressive agent was found to
reduce the number of infiltrated T cells in the kidney, reduce
oxidative stress in the urine, and attenuate salt-sensitive
hypertension and renal injuries in SS rats. Therefore, upregu-
lation of p67phox in T cells of SS rats could also contribute to
differences in salt-sensitivity between the two strains. The
relative contribution of the mTAL and infiltrated T cells toc.
Figure 4. Salt-Sensitive Hypertension and
Renal Oxidative Stress Are Significantly
Attenuated in the p67phox–/– Rats Compared
to WT Littermates
(A) Mean arterial pressure (MAP) of 5- to 6-week-
old rats on 0.4% and 8% salt diet (n = 8–11 rats/
strain). yp < 0.001 significant difference between
strains at that time point.
(B) Outer medullary NAD(P)H oxidase activity on
D14-HS (n = 6–9 rats/strain). *p < 0.05 significant
difference from WT.
(C) Outer medullary superoxide on D14-HS (n =
6–9 rats/strain). *p < 0.05 significant difference
from WT.
(D) Renal interstitial H2O2 (n = 5–8 rats/strain). *p <
0.05 significant difference from WT.
Data are presented as mean values ± SE.
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determined.
Finally, despite the crucial role of renal p67phox in the devel-
opment of salt-sensitive hypertension, the role of this gene
should still be examined in vascular systems and the central
nervous system. Although SNPs in human p67phox have not
been found to be associated with hypertension in genome-
wide association studies, the present study suggests that strat-
ification of the populations based on salt-sensitivity may
uncover an association. Our studies also suggest that inhibitors
targeting p67phox for the treatment of salt-sensitive hyperten-
sion should be explored.
EXPERIMENTAL PROCEDURES
Animals
Male rats were obtained at weaning from colonies developed and maintained
at the Medical College of Wisconsin under controlled environmental condi-
tions. They were provided water ad libitum and maintained on a purified
AIN-76A rodent food (Dyets, Bethlehem) containing 0.4% NaCl (LS) since
weaning. Some groups were switched to an 8% NaCl diet (HS) at 6 to 7 weeks
of age. All experimental protocols were approved by the MCW Institutional
Animal Care and Use Committee. Inbred congenic SS.13BN26 was generated
as previously described (Cowley et al., 2001; Moreno et al., 2007).
Tissue Collection
Rats were anesthetized with an intraperitoneal injection of pentobarbital
(50 mg/kg). Both kidneys were removed and hemisected. The outer medulla
was quickly removed and snap-frozen in liquid N2 and stored at 80C.
Frozen tissues were used for either DNA or RNA extraction or for preparation
of tissue homogenates to perform NAD(P)H oxidase activity assays or
western blots.Cell Metabolism 15, 201–208Real-Time Quantitative Reverse-
Transcription PCR
Total RNA was extracted from OM with TRIzol
(Invitrogen). The qRT-PCR reaction mixture con-
tained 13 SYBR Green PCR master mix (Invitro-
gen), 0.25 U/ml MultiScribe reverse transcriptase
(Applied Biosystems), 0.4 U/ml RNase inhibitor
(Applied Biosystems), 400 nM forward and
reverse primers, and 8 ng total RNA. qRT-PCR
reactions were carried out with the ABI Prism
7900HT system (Applied Biosystems) (Morrison
et al., 2004). 18S rRNA was used as an internalcontrol. Primers to amplify complementary DNA (cDNA) of p67phox were de-
signed by Primer Express version 2 (Applied Biosystems) and are as follows:
Forward (fw) primer: 50-AGCAGAAGAGCAGTTAGCATTGG-30
Reverse (rv) primer: 50-TGCTTTCCATGGCCTTGTC-30.
Western Blot
Outer medullary tissue was homogenized and processed as previously
described (Taylor et al., 2006). Protein concentrations were determined using
a Coomassie blue protein assay (Biorad) with bovine serum albumin as a stan-
dard. Lysates were mixed with laemmli sample buffer (BIO-RAD) and were
heated to 100C for 5 min, then loaded onto a 7.5%, 4%–20%, or 10%–
20%Tris SDS-PAGE gel (BIO-RAD) and transferred to a PVDFmembrane (Bio-
rad). Membranes were blocked for 1 hr in 13TBS-T (TBS [BIO-RAD] + 0.1%
Tween20 [Sigma]) containing 5% nonfat dry milk at room temperature and
then incubated at 4C overnight (16–18 hr). Membranes were incubated in
a primary antibody at room temperature for 2 hr, and then washed 5 min
each time for four times in 13TBS-T. Membranes were incubated in
a secondary antibody at room temperature for 1.5 hr, and washed 5 min
each time for four times in 13TBS-T. The films were developed with Immun-
StarTM HRP peroxide reagent (BIO-RAD). The films were scanned and the
intensities of the target bands were quantified using Imagequant program
(Amersham Biosciences). b-actin was used for loading control. Primary anti-
bodies were: p67phox(Millipore), 1:125; p22phox(Sigma), 1:200; gp91phox(BD),
1:1000; p47phox(Santa Cruz), 1:1000; Rac1(Millipore), 1:1000; and b-actin
(Santa Cruz), 1:1000.
Chronic Measurement of Arterial Blood Pressure
MAP was measured by radiotelemetry (De Miguel et al., 2011). Five- to six-
week-old male rats were anesthetized and surgically prepared with an im-
planted gel-filled catheter in the right carotid artery. This catheter was attached
to a transmitter (DSI) that was anchored subcutaneously between the scap-
ulae. Baseline MAP was obtained daily from 9 am to 12 pm over a 3 to 4 day, February 8, 2012 ª2012 Elsevier Inc. 205
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Figure 5. Renal Injury Is Significantly Reduced in p67phox–/– Rats
Compared to WT Littermates
(A and B) Proteinuria (A) andmicroalbuminuria (B) of p67phox/ andWT rats on
LS, D7-HS, and D14-HS diet (n = 6 rats/strain). yp < 0.01 significant difference
from WT at the same time point.
(C–E) Histological staining and quantitative analyses of renal injury markers in
p67phox/ and WT littermates on D14-HS diet. Trichrome staining for the
quantification of protein casts (n = 7 rats/strain) (C), a-SMA immunostaining for
fibrosis (n = 6 rats/strain) (D), and ED-1 immunostaining (n = 5 rats/strain) (E)
are shown. *p < 0.05 significant difference from WT.
(F) Cortical glomerular injury of superficial glomeruli (n = 7 rats/strain). *p < 0.05
significant difference from WT.
Data are presented as mean values ± SE.
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206 Cell Metabolism 15, 201–208, February 8, 2012 ª2012 Elsevier Inperiod following a 5 to 7 day surgical recovery after catheter implantation. The
diet was then switched from 0.4% LS to 8% HS. MAP was measured on days
1–3, 7, 10, and 14 of the HS diet.
Sequencing the Coding Region of Rat p67phox
Total RNA was extracted from outer medullary tissue and reverse transcribed
to cDNA with an oligo-dT primer (Invitrogen). PCR primers were designed by
DNASTAR program. PCR products were cloned into the pCR4-TOPO vector
(Invitrogen) and are sequenced. Primers used to amplify the coding region
were as follows:
fw primer: 50-caccatcctgtcttctagtaagca-30
rv primer: 50-ctatacttctctgggagtgccttc-30.
Sequencing Promoter Region of rat p67phox
Genomic DNA was extracted from outer medullary tissue. PCR primers ampli-
fying the 3000 bp prior to the translation start site were design by DNASTAR.
PCR products were sequenced directly. A 1700 bp sequence prior to the
translation start site was assembled and analyzed. Primers are as follows:
fw primer: 50-tgtttgaggtaggttttagaaa-30
rv primer: 50-ggttaggtgcttactagaagacag-30.
Building p67phox Promoter Constructs
PCR products from genomic sequencing were used as the template to build
promoter constructs. Primers to amplify the promoter region containing all
of the genetic variances are as follows:
fw1 primer (for SS.13BN26): 50-aactcgagcttcttaaattttttttttttatttattca-30
fw2 primer (for SS): 50-aactcgagcttcttaaatggccagagtggc-30
rv primer: 50- aaaaaagatctaggatggtagttcaaggtgtctc-30.
The underlined sequences indicate restriction enzyme target sites. PCR
products were cloned into the XhoI-BglII site of pGL4.81 [hRlucCP/Neo] vector
(Promega) (Liu et al., 2009). Renilla luciferase reporter constructs containing
either the SS or SS.13BN26 p67phox promoter segment were verified by
sequencing. Promoter vectors were prepared with an E.Z.N.A. Endo-Free
Midi Plasmid Kit (Omega).
Transfection and Luciferase Activity Assay
Immortalized rat medullary thick ascending limb cells (raTAL) were cultured
in REGM Renal Epithelial Cell Growth Medium (BulletKit, Lonza) and
passaged (Eng et al., 2007). Once 90% confluency was reached, the cells
were seeded onto 96-well plates. When raTAL cells reached 40%–50%
confluency, reporter constructs were transfected using Lipofectamine
2000 (Invitrogen). During transfection, REGM media was replaced by
Opti-MEM I Reduced Serum Media (Invitrogen). A control plasmid pGL2
(Promega) was also cotransfected to adjust for transfection efficiency.
Four hours after transfection, Opti-MEM I Reduced Serum Media was
switched back to culture media REGM. Cells were incubated overnight,
and the promoter luciferase activity was measured by a dual luciferase-
reporter assay system (Promega). Luminescence was measured with
a high-throughput Analyst HT 96.384 microplate reader (Molecular Devices)
(Liu et al., 2009).
Production of the p67phox-Null Mutant Colony
Zinc Finger Nucleases (ZFNs) targeting rat p67phox exon 2 was designed by
Sigma. The target sequence contains CTCTACTACAGCATGgagaag
TAAGTGGTGTCGGAGTGT, where each ZFN binds to each underlined
sequence on complementary strands. mRNA encoding the p67phox ZFNs
were injected into embryos from SS rats and transferred to pseudopregnant
SS females. The SURVEYOR Nuclease Assay was used to detect ZFN-medi-
ated genome editing (Geurts et al., 2009; Geurts et al., 2010). The PCR primers
used to amplify the target site were as follows:
fw primer: 50-tgtaaaacgacggccagttcaccttgcattgctgaatc-30
rv primer: 50-aactgcccagaaagagcaag-30.c.
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a 5 bp deletion and the other allele with an 11 bp deletion. This rat was back-
crossed with an SS female. The offspring of the backcross were either hetero-
zygous (5 bp deletion/+) or heterozygous (11 bp deletion/+). Female and male
heterozygous rats (5 bp deletion/+) were chosen for intercross. Fluorescent
genotyping was used to distinguish homozygous p67phox-null mutant
(p67phox/) rats from the WT littermates. PCR products amplifying the ZFNs
target site were mixed with Liz-600 size standard (Applied Biosystems) and
were loaded on an ABI3730 sequencer. The results were analyzed by Gene-
Mapper 4.0 software (Applied Biosystems). WT animals amplified at 325 bp
while homozygous mutant animals amplified at 320 bp.
Respiratory Burst Assay
Six- to seven-week-old WT and p67phox/ rats fed the HS diet for 14 days
were used. Rats were anesthetized with an intraperitoneal injection of pento-
barbital (0.1 ml/100 g body weight). Eighty milliliters of saline were injected
in to the abdominal cavity followed by a small midline incision. The excess fluid
was drained in a beaker. The collected fluids were centrifuged at 400 g for
10 min. Histopaque-1083 (Sigma) was used to isolate mononuclear cells (De
Miguel et al., 2010). Ninety percent of collected cells were viable confirmed
by trypan blue (BI) staining. Using flow cytometry, 70%–75% of the collected
cells were identified as CD11b+ macrophages, the major cells that generate
the respiratory burst. 10% of the collected cells were CD3+ T cells, and 10%
were CD45Ra+ B cells. Collected cell pellets were resuspended in 1 ml
Dulbecco’s Modified Eagle Medium (Invitrogen) and were aliquot into three
wells on a clear-bottom 96-well plate (Bioexpress). The plate was incubated
at 37C for 2 hr. Each well contained around 1 3 106 cells. Media were then
removed and replaced with 0.3 ml of 1 mM luminol derivative L-012 (Wako
Pharmaceuticals) dissolved in Hank’s balanced salt solution (Invitrogen).
Luminescence of L-012 was used as an index of superoxide production.
Luminescence was measured at 37C on FLUOstar Omega machine (BMG
Labtech) for baseline recording. Phorbol 12-myristate 13-acetate (PMA),
a PKC activator, was added to each well to yield a final concentration of
135 mM. Luminescence was then measured every 5 min for 30 min.
Detection of Total O2
.– and NAD(P)H Oxidase Activity
by 2-Hydroxyethidium Fluorescence
Outer medullary homogenate protein (20 mg) was incubated with dihydroethi-
dium (20 mmol/liter), with salmon testes DNA (0.5 mg/ml), and with or without
100 mmol/liter diphenylene iodonium (DPI; Sigma), an inhibitor of NAD(P)H
oxidase. Oxyethidium fluorescence was measured at an excitation of
485 nm and an emission of 570 nm on a SpectraFluor microplate reader
(TECAN) every 5 min for 35 min (37C) (Taylor et al., 2006). The maximal
increase of fluorescence within 35 min was used as an index of total O2
. level.
The portion of oxyethidium fluorescence after DPI inhibition was used as an
index of NAD(P)H oxidase activity.
Acute Microdialysis
WT and p67phox/ rats were anesthetized with ketamine (20 mg/kg, IM) and
inactin (50 mg/kg, IP) and placed on a temperature-controlled surgical table
maintained at 37C. The femoral artery was catheterized to record arterial
pressure. The femoral vein was catheterized to infuse saline containing 2%
BSA in saline (0.1 ml/hr/100 g) to maintain constant blood volume. The left
kidney was isolated and prepared for in vivo microdialysis (Jin et al., 2009).
After a 1 hr equilibration period, dialysate effluent was collected over two
30 min intervals. Renal medullary interstitial H2O2 concentrations were deter-
mined by fluorescence spectrometry with the Amplex Red Hydrogen Peroxide
Assay Kit (Molecular Probes).
Histological Staining Analysis
Rats were anesthetized and the left kidney was perfused with 10 ml 0.9%
saline to flush the blood out, and the kidney was then removed and placed
in phosphate buffer containing 10% formaldehyde. Kidneys were paraffin
embedded in an automatic tissue processor (Microm). Three-micron cut
sections were mounted on siliconized/charged slides. A robotic DAKO autos-
tainer (Dako Cytomation) was used for all staining procedures. All images were
captured with a Nikon E600 (Fryer) microscope equipped with a Spot Insight
color CCD camera (Diagnostic Instruments). Gomori’s trichrome, a-SMACell M(Dako Cytomation) and ED1 (Serotec) staining and quantification were per-
formed as previously described (Mori et al., 2008). Glomerular injury was quan-
tified as previously described (Mori and Cowley, 2004).
Measurement of Albumin and Protein in Urine
Rats were placed in metabolic cages for overnight urine collection (18 hr).
Microalbuminuria was quantified with an Albumin Blue 580 (Molecular Probes)
fluorescence assay. Proteinuria was quantified with Weichselbaum’s biuret
reagent on an ACE autoanalyzer (Alfa Wassermann).
Statistical Analysis
Data are presented as mean values ± one standard error. To assess the differ-
ences between two groups, t tests were performed. Empirical p values were
obtained through 100,000 permutation tests. Two-way analysis of variance
(ANOVA) for repeated-measures was used to analyze blood pressure, micro-
albuminuria and proteinuria data. For comparison of the difference between
the strains on a specific day, a t test was used followed by 100,000 permuta-
tion tests. Multiple comparisons were adjusted with a Bonferroni correction.
For other multiple group comparisons, a two-way ANOVA was performed.
Multiple comparisons were adjusted with a Bonferroni correction. All of these
data analyses were implemented using the R statistical package.
ACCESSION NUMBERS
Gene sequences have been deposited in NCBI’s GenBank and are accessible
under accession numbers JN864041, JN864042, JN864043, JN864044,
JN864045, and JN864046.
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